Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) possesses a positive-sense single-stranded RNA genome. Mutations of this genome may occur over time, and while these changes are not unexpected, specific mutations may alter important characteristics of the virus. When viral genomic changes are associated with potential altered transmission, virulence, or vaccine efficacy, they may be identified as a particular SARS-CoV-2 Variant of Concern (VOC). Currently, there are three commonly discussed VOCs.

Following the first IQMH proficiency testing (PT) survey for SARS-CoV-2, the IQMH Virology Scientific Committee published Committee Comments with recommendations for participants.

IQMH is resuming accreditation assessment activities as of October 26 using a revised approach. To the extent possible, we will be conducting assessments remotely in order to reduce the number of assessors on-site to as few as possible for the shortest time needed. You will be contacted by the Staff Technologist assigned to your assessment with specific details. Thank you for your continued cooperation at this difficult time. 

As previously communicated, IQMH has been operating as a virtual office since the physical office was closed in mid-March. We are now planning to gradually re-open with a very limited number of staff present on-site commencing on July 13, 2020 or thereabouts. However, the vast majority of IQMH staff will continue to work from home during this early phase. 

To defeat COVID-19 everyone has to do their part. Accreditation Canada, Health Standards Organization Institute for Quality Management in Healthcare and our partners have released a suite of resources to support health care and social service workers and their organizations.